Skip to content
Bored Studies
Recruiting

Pro-2-Cool Pivotal Trial II

TecTraum Inc. · NCT06929923

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 13–21 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Not applicable
Target enrollment
66
US sites recruiting
1
Study start
February 20, 2025
Record last updated
August 12, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study is being conducted to determine the clinical safety and efficacy of Pro-2-Cool mediated head and neck cooling when applied after concussion and improved symptomatology among adolescent athletes as quantified by post-concussion symptom severity (PCSS) score.

Being studied: Pro2Cool Device; Sham Cooling Garment Device

Conditions: Concussion, Mild

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Males and females, 13-21 years of age
  • Confirmed concussion diagnosis consistent with American Congress Rehabilitation Medicine guidelines 21, without any of the following:
  • Glasgow Coma Scale (GCS) score of less than 13 at 30 minutes post-injury
  • Loss of consciousness greater than 30 minutes
  • Post-traumatic amnesia lasting over 24 hours
  • Glasgow Coma Scale (GCS) ≥ 13 at the time of initial injury for study enrollment.
  • Post-Concussion Symptom Scale Score minimum of 15
  • Initial provider visit is within 7 days of injury
  • In generally good health as confirmed by medical history and determined by site investigator or designated trained healthcare professional under the supervision of the principal investigator.
  • Has informed consent obtained per protocol and as required per Institutional Review Board

Exclusion Criteria

  • Age \< 13 years or > 21 years
  • Inability to understand the study requirements or provide informed consent
  • Cleared to return to play during initial visit
  • Prior participation in a Pro2Cool Clinical Study
  • Serious traumatic brain injury as evidenced by worsening symptoms:
  • Vomiting > 2 episodes following injury
  • Seizure
  • Hospitalization
  • Radiology scan indicating brain bleed
  • Slurred speech which has not resolved within 72 hours of concussive injury
  • Physical (e.g., head or neck injury that requires medical treatment) or mental disability hindering adequate response to assessment of symptoms
  • Hemodynamic instability/medical condition requiring further acute life-saving medical intervention
  • History of psychiatric disorder that includes suicide attempts within the last 6 months, unmanaged depression or anxiety, hospitalization for psychiatric treatment within the last 6 months
  • Known brain mass, intracranial hemorrhage, skull fracture
  • Scalp abnormalities including laceration or bleeding
  • Presence of ventriculoperitoneal (VP) shunt
  • Known hematological malignancies, including, but not limited to: multiple myeloma, leukemia, and lymphoma
  • Known history of Reynaud's Disease compromised liver function, cold agglutination, cold sensitivity, cryoglobulinemia, cryofibrinogenemia, and/or a history of severe migraines
  • Known or disclosed pregnancy or breast-feeding
  • Sustains another head or neck injury at the time of concussive injury which requires medical treatment

Recruiting US locations

  • Akron Children's Hospital

    Akron, OH 44308

    Site contact: Brian Reilly, MD

Study contacts (from the official record)

  • John Zak, MD, MBA · 216-789-7676 · jzak@tectraum.com
  • Rebecca Zickert · rebecca.zickert@brightresearch.com
Pro-2-Cool Pivotal Trial II (NCT06929923) | Bored Studies